Marzetti (MZTI) Q4 2026 earnings review
Margin Expansion Masks a Severe Core Volume Deceleration
Marzetti delivered a optically decent Q4, but the underlying health of the business is deteriorating. A record Q4 gross profit of $114.0M and a massive 220 bps margin expansion drove a 9% increase in Adjusted EPS. However, this profit efficiency masked a reversing top-line. Consolidated net sales fell 2.2%. More alarmingly, while the newly integrated Bachan's acquisition added 520 basis points of volume growth to the Retail segment, reported Retail volume still shrank 1.7%. This implies organic legacy volumes collapsed roughly 6.9%. Management is executing flawlessly on supply chain and cost controls, but consumer demand for the core portfolio is breaking.
🐂 Bull Case
Gross margin expanded 220 bps to 24.5%. Management's manufacturing optimization strategy (closing Milpitas, ramping Atlanta) is yielding significant structural profitability improvements.
In just two months, the Bachan's acquisition contributed $15.4M to top-line, driving 640 bps of Retail sales growth and proving the M&A thesis works.
🐻 Bear Case
Retail volume declined 1.7% overall. Backing out Bachan's 520 bps contribution reveals that organic legacy volume plunged roughly 6.9% YoY.
Adjusted Foodservice net sales contracted 0.1%. Despite partnerships with winning QSRs, the broader restaurant macro environment is weighing heavily on the segment.
⚖️ Verdict: 🔴
Bearish. The structural margin improvements are commendable, but a consumer staples company cannot sustain long-term earnings growth when its organic retail volumes are declining at a near 7% clip.
Key Themes
The Hidden Core Volume Collapse
Management touted a 0.9% increase in Retail net sales, but the data contradicts the positive narrative. Reported Retail volume declined 1.7%. Management explicitly noted that Bachan's accounted for 520 basis points of Retail segment volume growth. This implies that legacy brand volume actually decelerated by roughly 6.9%. Lapping previous pipeline fills (Chick-fil-A, Sister Schubert's) does not fully explain a drop of this magnitude.
Flawless Execution on Margin Expansion
The operational restructuring is delivering undeniable results. Gross profit increased $7.9M to a Q4 record of $114.0M, with margin accelerating 220 bps to 24.5%. The closure of the Milpitas facility (which also generated an $18.5M gain on sale) and ongoing cost savings programs are providing a vital buffer against the collapsing top-line.
Bachan's and M&A Strategy Validated
Closing on May 1, Bachan's immediately altered the P&L trajectory. It added $15.4M in sales, driving 640 bps of Retail sales growth. Circana scanner data validates the momentum, with the brand growing retail sales 8.7% and total distribution points up 16.6%. This acquisition is effectively single-handedly keeping the Retail segment afloat.
Texas Roadhouse Licensing Continues to Surge
Product innovation through licensing remains a structural driver. Texas Roadhouse dinner rolls are a standout performer, with Circana retail scanner data showing sales up 28.1% for the quarter and an accelerating 76.3% for the full fiscal year.
Foodservice Growth Algorithm Stalling
The Foodservice segment trend is stable but stagnant. Reported net sales fell 5.3%, and even after stripping out the $12.2M non-core TSA sales from the prior year, Adjusted Foodservice sales still slipped 0.1%. Core sales volume improved a mere 0.1%. The strategy of aligning with 'winning' QSRs is currently only enough to tread water, not grow.
New Macro Headwind: Cyclospora Outbreak
In addition to noting the drag of broader U.S. economic performance on consumer behavior, management explicitly flagged that they 'continue to monitor the impact of the Cyclospora outbreak on product demand and sales' in their FY27 outlook. This introduces a new, unpredictable foodborne illness macro risk to the produce-adjacent categories (dips, dressings) heading into next year.
Other KPIs
Accelerating. Cash from operations grew $22.3 million YoY to a record high. This robust cash generation easily funded $108.8M in dividend payments and $36.3M in share repurchases, while absorbing the cash portion of the $400M Bachan's acquisition (alongside a $200M term loan).
Reported SG&A spiked $12.3 million YoY. However, $10.5 million was directly tied to acquisition costs, and $1.6 million was noncash amortization for Bachan's intangibles. Excluding these one-time and non-cash items, core SG&A was effectively flat, demonstrating excellent cost discipline in a high-inflation environment.
Guidance
Stable. Management anticipates aggregate input costs will rise moderately. The company plans to deploy inflationary pricing and ongoing cost savings programs to fully offset this, maintaining their focus on continued margin expansion.
Accelerating top-line implied, driven entirely by inorganic inputs. Management expects sales to benefit from a full year of Bachan's and new item introductions for legacy and licensed brands. However, they caveated this with warnings about U.S. economic performance and consumer behavior.
Key Questions
Organic Volume Contraction
By our math, backing out Bachan's implies your core legacy Retail volumes fell nearly 7% this quarter. At what point do pricing actions and consumer fatigue permanently impair the base business, and what is the timeline for core volumes to turn positive?
Cyclospora Outbreak Exposure
You explicitly called out the Cyclospora outbreak in your FY27 outlook. Can you quantify the current or expected demand destruction to your produce dip and refrigerated dressing categories stemming from this specific issue?
Next Phase of Margin Expansion
With the Milpitas facility successfully closed (and sold) and the Atlanta facility ramping up, you've exhausted a major lever for supply chain optimization. Where will the next 50-100 basis points of gross margin improvement come from in FY27?